FAQ

Are you funding any research into a vaccine (or cure) for coeliac disease?

Coeliac UK funded the initial project of Professor Bob Anderson which identified the most important gluten peptides causing problems for people with coeliac disease. This research formed the basis of further research and eventually the development of the NexVax2 vaccine.  

Unfortunately, this work was halted in 2019 as results showed that it did not provide sufficient protection to gluten exposure. Coeliac UK is committed to funding research which provides a greater understanding of the disease process to identify new targets for treatment or a cure. 

All frequently asked questions